Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody designed to target a specific variant of the MUC5AC glycoprotein. This antibody exhibits high specificity for tumor-associated MUC5AC variants frequently expressed in colorectal and pancreatic cancers. Ensituximab's targeted mechanism of action makes it a valuable tool for research focused on these types of malignancies, providing potential insights into disease pathways and therapeutic approaches.
Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody designed to target a specific variant of the MUC5AC glycoprotein. This antibody exhibits high specificity for tumor-associated MUC5AC variants frequently expressed in colorectal and pancreatic cancers. Ensituximab's targeted mechanism of action makes it a valuable tool for research focused on these types of malignancies, providing potential insights into disease pathways and therapeutic approaches.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
